IndulgeRx gets WIPO publication for three IRX FOODSCORE patents

IndulgeRx Brands says WIPO has published all three of its PCT patent applications for the AI-powered IRX FOODSCORE platform after each one received an all-A international search report. The company says the result strengthens its intellectual property position as it prepares for investor and partnership talks.

Why it matters: - IndulgeRx says the WIPO publication and all-A search reports give the company independent validation of its IRX FOODSCORE intellectual property. - The milestone could strengthen the company’s hand in seed and Series A fundraising, plus strategic partnership talks. - The company says the patent record de-risks a platform it plans to monetize across consumer apps, CPG licensing, retail, payers, providers, pharmacists, sports performance, research and government use.

What happened: - WIPO published all three of IndulgeRx Brands Inc.’s Patent Cooperation Treaty applications on July 23, 2026. - The applications cover IRX FOODSCORE as a system, software and business method. - Each application received an all-A International Search Report from the U.S. International Searching Authority. - The published application numbers are WO2026156106 A1 for IRX FS SOFTWARE, WO2026156110 A1 for IRX FS METHOD and WO2026156104 A1 for IRX FS SYSTEM.

The details: - The ISR ratings mean the examiner found no X citations and no Y citations across the three filings. - Every claim was found to be novel, inventive and industrially applicable, the company said. - The written opinions affirmed claims 1–15 in each application. - The examiner concluded that combining prior art would be “impermissible hindsight.” - The examiner also found that combining existing technologies would not provide advantages over the application or would require complexity beyond ordinary skill. - The company said one filing required a minor procedural claim-grouping clarification that did not affect the A grades or novelty findings. - IndulgeRx says the patent priority date is Jan. 16, 2025. - The company said the filings are publicly accessible through WIPO PATENTSCOPE. - IRX FOODSCORE analyzes health history, age, gender, medications and goals against ingredients, additives, preservatives and preparation methods. - The platform generates two outputs: a Relevant Nutrition Score and a Relevant Risk Score. - The company says the system turns “is this good for me?” into one IRX FOODSCORE answer. - IndulgeRx describes itself as a privately held, founder- and friends-and-family-funded nutrition technology company based in Woods Cross, Utah.

Between the lines: - The company is framing the patent result as a rare outcome in a global examination system used by major tech and health companies. - The public WIPO record may help IndulgeRx argue that IRX FOODSCORE is differentiated from prior work in health AI and nutrition scoring. - The investor message is clear: IndulgeRx wants the patent result to serve as evidence that a small team can win protection in a process usually dominated by much larger companies.

What's next: - IndulgeRx is likely to use the published patents in ongoing seed round and Series A discussions. - The company also expects the IP result to support future licensing and strategic partnership conversations. - More information is available at IndulgeRx, IRX FOODSCORE and Fight Back Foods.

The bottom line: - IndulgeRx now has three publicly published WIPO patent applications and all-A search reports behind its IRX FOODSCORE platform, a notable IP milestone the company says boosts its commercial and fundraising case.